SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-12-000784
Filing Date
2012-11-14
Accepted
2012-11-14 10:23:37
Documents
5
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED SEPTEMBER 30, 2012 nymox6k3q120930.htm 6-K 5090
2 QUARTERLY REPORT FOR THE QUARTER ENDED SEPTEMBER 30, 2012 exhibit99-1.htm EX-99.1 306321
3 CEO CERTIFICATIONS exhibit99-2.htm EX-99.2 6990
4 CFO CERTIFICATIONS exhibit99-3.htm EX-99.3 6902
5 exhibit99-1x1x1.jpg GRAPHIC 11102
  Complete submission text file 0001176256-12-000784.txt   341772
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 121201564
SIC: 2835 In Vitro & In Vivo Diagnostic Substances